UK markets closed
  • NIKKEI 225

    27,820.40
    +42.50 (+0.15%)
     
  • HANG SENG

    19,518.29
    +842.94 (+4.51%)
     
  • CRUDE OIL

    77.39
    +0.46 (+0.60%)
     
  • GOLD FUTURES

    1,781.70
    +0.40 (+0.02%)
     
  • DOW

    33,947.10
    -482.78 (-1.40%)
     
  • BTC-GBP

    13,926.67
    -182.91 (-1.30%)
     
  • CMC Crypto 200

    401.03
    -10.19 (-2.48%)
     
  • ^IXIC

    11,239.94
    -221.56 (-1.93%)
     
  • ^FTAS

    4,143.21
    +4.40 (+0.11%)
     

IDEX Biometrics: Subscription Rights Exercise – 18 Nov 2022

IDEX BIOMETRICS ASA
IDEX BIOMETRICS ASA

The board of directors of IDEX Biometrics ASA has resolved to issue in total 246,167 ordinary shares at price NOK 0.15 per share to an employee who has exercised incentive subscription rights. The incentive subscription rights were issued under the company’s 2019 incentive subscription rights plan, which was approved by the annual general meeting on 9 May 2019.

The employee has paid the subscription amount to the company.

Following the issue, the company's share capital will be NOK 167,637,217.35 divided into 1,117,581,449 shares each with a nominal value of NOK 0.15. Following the exercise, there are 82,865,280 incentive subscription rights outstanding.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions.  Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act